Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1–2 and cN0 breast cancer

Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes

(2018) Yvette Andersson et al.   BREAST CANCER RESEARCH AND TREATMENT

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

(2017) David Cameron et al.   LANCET

Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer

(2017) Hideo Shigematsu et al.   Breast Cancer

Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer

(2017) Rikiya Nakamura et al.   Breast Cancer

Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer

(2016) Natalia S. Tucker et al.   ANNALS OF SURGERY

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

(2016) Armando E. Giuliano et al.   ANNALS OF SURGERY

Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound

(2016) Amy E. Cyr et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

(2016) Fatima Cardoso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of the Stage IB Designation of the American Joint Committee on Cancer Staging System in Breast Cancer

(2015) Elizabeth A. Mittendorf et al.   JOURNAL OF CLINICAL ONCOLOGY

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

(2015)   LANCET

Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

(2015) Sara M. Tolaney et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

(2014) Mila Donker et al.   LANCET ONCOLOGY

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)

(2012) Oreste Gentilini et al.   BREAST

Preoperative Ultrasound-Guided Needle Biopsy of Axillary Nodes in Invasive Breast Cancer

(2011) Nehmat Houssami et al.   ANNALS OF SURGERY

Effect of Occult Metastases on Survival in Node-Negative Breast Cancer

(2011) Donald L. Weaver et al.   NEW ENGLAND JOURNAL OF MEDICINE

Breast Cancer Survival in Relation to the Metastatic Tumor Burden in Axillary Lymph Nodes

(2010) Yvette Andersson et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

(2010) David N Krag et al.   LANCET ONCOLOGY

Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients

(2009) Mona Sanghani et al.   CANCER